再生障碍性贫血(以下简称再障)是由于骨髓造血机能障碍所引起的一种血液病,好发于青壮年,其发病率约为6/10万人口,且有逐年增高趋势。长期以来对本病缺乏有效的治疗方法,随着现代科学技术的进步,对再障的病因、发病机理和治疗进行了一系列深入研究,因而使本病的预后有了明显的改观。 Aplastic anemia (hereinafter referred to as aplastic anemia) is due to bone marrow hematopoietic dysfunction caused by a blood disease, occurs in young adults, the incidence rate of about 6/100000 population, and the trend of increasing year by year. For a long time, there is no effective treatment for this disease. With the progress of modern science and technology, a series of in-depth researches have been conducted on the etiology, pathogenesis and treatment of aplastic anemia, thus the prognosis of this disease has been significantly improved.